SpyGlass Pharma Rings the Opening Bell

About This Event

SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Patrick Mooney, Chief Executive Officer rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore